Abstract
The noninvasive detection of cell death has significant diagnostic values. Molecular events in apoptosis and necrosis are a source of valuable surrogate markers for the detection of cell death. Two classes of imaging agents are being developed for imaging caspase activities and redistribution of membrane phospholipids, respectively. The current review looks at the molecular recognition mechanisms of existing and emerging agents in the physiological context of the surrogate markers. The imaging of caspase activities using substrate-derived agents has the advantage of high selectivity and can potentially allow the dissection of individual apoptotic pathways in vivo. The detection of membrane phospholipid redistribution using extracellular agents has the advantage of high target density and accessibility. The strength and limitations of each approach are discussed. Overall, in order to develop appropriate imaging techniques, it is important to understand the interactions between the agent and surogate markers on a molecular as well as physiological level. Such information is vital for fully appreciating the potential utilities of an imaging strategy.
Current Pharmaceutical Biotechnology
Title: Molecular Recognition Mechanisms for Detecting Cell Death In Vivo
Volume: 11 Issue: 6
Author(s): Ming Zhao
Affiliation:
Keywords: Apoptosis, Necrosis, Imaging, Probe
Abstract: The noninvasive detection of cell death has significant diagnostic values. Molecular events in apoptosis and necrosis are a source of valuable surrogate markers for the detection of cell death. Two classes of imaging agents are being developed for imaging caspase activities and redistribution of membrane phospholipids, respectively. The current review looks at the molecular recognition mechanisms of existing and emerging agents in the physiological context of the surrogate markers. The imaging of caspase activities using substrate-derived agents has the advantage of high selectivity and can potentially allow the dissection of individual apoptotic pathways in vivo. The detection of membrane phospholipid redistribution using extracellular agents has the advantage of high target density and accessibility. The strength and limitations of each approach are discussed. Overall, in order to develop appropriate imaging techniques, it is important to understand the interactions between the agent and surogate markers on a molecular as well as physiological level. Such information is vital for fully appreciating the potential utilities of an imaging strategy.
Export Options
About this article
Cite this article as:
Zhao Ming, Molecular Recognition Mechanisms for Detecting Cell Death In Vivo, Current Pharmaceutical Biotechnology 2010; 11 (6) . https://dx.doi.org/10.2174/138920110792246591
DOI https://dx.doi.org/10.2174/138920110792246591 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies
Clinical Cancer Drugs Inhibitors of ABL and the ABL-T315I Mutation
Current Topics in Medicinal Chemistry Novel Concepts in the Development of Platinum Antitumour Drugs: An Update
Medicinal Chemistry Reviews - Online (Discontinued) Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
Anti-Cancer Agents in Medicinal Chemistry Vascular Inflammation During Human Rickettsioses: An Essential Host Response and a Potential Target for Supplemental Therapy
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Novel Insights in Molecular Mechanisms of CLL
Current Pharmaceutical Design Medicinal Plants and Cancer Chemoprevention
Current Drug Metabolism Relaxin-Like Peptides in Neoplastic Lesions
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Pharmacogenomics of Human ABC Transporters: Detection of Clinically Important SNPs by SmartAmp2 Method
Current Pharmaceutical Biotechnology New Immunosuppressants: Immunosuppression and Immunomodulation
Medicinal Chemistry Reviews - Online (Discontinued) Histone Deacetylase Inhibitors in Cancer Treatment: A Review of the Clinical Toxicity and the Modulation of Gene Expression in Cancer Cells
Current Pharmaceutical Biotechnology Plant Cells as Pharmaceutical Factories
Current Pharmaceutical Design Design of Magnetic Nanoparticles-Assisted Drug Delivery System
Current Pharmaceutical Design New Insight into P-Glycoprotein as a Drug Target
Anti-Cancer Agents in Medicinal Chemistry Anti-Tumor Necrosis Factor-Alpha (TNF-α) Treatment Strategies in Crohns Disease
Recent Patents on Inflammation & Allergy Drug Discovery Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer
Current Cancer Drug Targets Importance of Wnt Signaling in the Tumor Stroma Microenvironment
Current Cancer Drug Targets Ring Opening of Tetrazole via Unusual Vilsmeir-Haack Reaction Forming Novel Triazenes
Letters in Organic Chemistry Leukopenia Associated with Risperidone Treatment
Current Drug Safety Mevalonate Pathway and Human Cancers
Current Molecular Pharmacology